Webinar to be held Tuesday, December 2nd, at 8:00 am ETREDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Jasper ...

Scientists have found that common foods can contain hidden contaminants formed during cooking or through environmental ...

MAIA Biotechnology, Inc. ( ($MAIA) ) has shared an announcement. On November 20, 2025, MAIA Biotechnology announced that its CEO, Vlad Vitoc, ...

Agios reported mixed results from a Phase 3 study of its drug Pyrukynd in sickle cell, raising doubts about the drug's ...

The global biotechnology CMO and CDMO market size is calculated at USD 74.01 billion in 2025 and is expected to reach around ...

US pharma major Johnson & Johnson (NYSE: JNJ) has halted its Phase IIb AuTonomy study after posdinemab failed to achieve a ...

An international team of scientists has found compelling evidence that early-infancy infection with respiratory syncytial ...

Company starts enrollment in Romania for Phase 2 THIO-101 Part C study of ateganosine as a treatment for advanced non-small cell lung cancer ...

New study shows RSV infection in early infancy can raise asthma risk later, especially in children with allergic family ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the ...

Oncolytics Biotech ( ($ONCY) ) has shared an update. Oncolytics Biotech Inc. announced on November 19, 2025, that it has aligned with the FDA on ...

Presenter: Vitaly Margulis, M.D., Professor of Urologic Oncology, University of Texas Southwestern ...